Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

371
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
371
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

69.4K
Overview
69.4K
Tissue Transplantation01:24

Tissue Transplantation

442
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
442

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementation of BSH 2020 irradiation guidelines for children with DiGeorge syndrome.

Transfusion medicine (Oxford, England)·2026
Same author

Quality of life of X-linked agammaglobulinemia patients in the United Kingdom.

Journal of human immunity·2026
Same author

International clinical consensus on leukocyte adhesion deficiency-I: Modified Delphi analysis.

The journal of allergy and clinical immunology. Global·2026
Same author

Treosulfan-fludarabine conditioning in infants with severe combined immunodeficiencies: Extended study of the UK paediatric treosulfan study.

British journal of haematology·2026
Same author

Pneumococcal Infective Endocarditis in two vaccinated Irish children; The Challenge of Non-Vaccine Serotypes and the Role of Host Immunity.

Irish journal of medical science·2026
Same author

Ketones and the NLRP3 inflammasome: you are what you eat.

Blood·2026

Related Experiment Video

Updated: Aug 6, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

7.9K

Recent advances in graft-versus-host disease.

Aisling M Flinn1,2, Andrew R Gennery1,2

  • 1Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, NE1 7RU, UK.

Faculty Reviews
|March 16, 2023
PubMed
Summary

Graft-versus-host disease (GVHD) remains a major challenge after hematopoietic stem cell transplant (HSCT), especially steroid-refractory cases. Further research and clinical trials are crucial for better prevention and treatment strategies.

Keywords:
Acute graft-versus-host diseasechronic graft-versus-host disease

More Related Videos

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
09:50

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Published on: February 11, 2019

9.8K
Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
10:29

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Published on: August 29, 2012

15.8K

Related Experiment Videos

Last Updated: Aug 6, 2025

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
08:05

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease

Published on: March 17, 2020

7.9K
Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice
09:50

Induction of Intestinal Graft-versus-host Disease and Its Mini-endoscopic Assessment in Live Mice

Published on: February 11, 2019

9.8K
Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
10:29

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model

Published on: August 29, 2012

15.8K

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Medicine

Background:

  • Acute and chronic graft-versus-host disease (GVHD) significantly contribute to morbidity and mortality following hematopoietic stem cell transplantation (HSCT).
  • Steroid-refractory GVHD presents a particular clinical challenge, highlighting unmet needs in current management strategies.

Purpose of the Study:

  • To review recent advancements in understanding the pathophysiology of acute and chronic GVHD.
  • To discuss current and emerging strategies for the prevention and management of GVHD, with a focus on steroid-refractory disease.

Main Methods:

  • This review synthesizes current literature on GVHD pathophysiology, prevention, and treatment.
  • It highlights challenges in research, including data acquisition and limited human tissue availability for studying steroid-refractory GVHD.

Main Results:

  • Progress in GVHD management is hindered by difficulties in obtaining high-quality evidence and addressing patient/donor/graft heterogeneity.
  • Limited availability of human tissue impedes the study of underlying pathophysiology, especially in steroid-refractory cases.

Conclusions:

  • Continued collaborative research is essential to elucidate GVHD pathophysiology, particularly in steroid-refractory disease.
  • Development of biomarkers for risk stratification and conducting well-designed randomized clinical trials are critical for optimizing GVHD prevention and treatment.